FR2669346B1 - RECOMBINANT POXVIRUS VACCINE AGAINST MEALS. - Google Patents

RECOMBINANT POXVIRUS VACCINE AGAINST MEALS.

Info

Publication number
FR2669346B1
FR2669346B1 FR9114256A FR9114256A FR2669346B1 FR 2669346 B1 FR2669346 B1 FR 2669346B1 FR 9114256 A FR9114256 A FR 9114256A FR 9114256 A FR9114256 A FR 9114256A FR 2669346 B1 FR2669346 B1 FR 2669346B1
Authority
FR
France
Prior art keywords
meals
vaccine against
recombinant poxvirus
poxvirus vaccine
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9114256A
Other languages
French (fr)
Other versions
FR2669346A1 (en
Inventor
Paoletti Enzo
Taylor Jill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virogenetics Corp
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Publication of FR2669346A1 publication Critical patent/FR2669346A1/en
Application granted granted Critical
Publication of FR2669346B1 publication Critical patent/FR2669346B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR9114256A 1990-11-20 1991-11-19 RECOMBINANT POXVIRUS VACCINE AGAINST MEALS. Expired - Lifetime FR2669346B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62161490A 1990-11-20 1990-11-20
US77686791A 1991-10-22 1991-10-22

Publications (2)

Publication Number Publication Date
FR2669346A1 FR2669346A1 (en) 1992-05-22
FR2669346B1 true FR2669346B1 (en) 1995-07-21

Family

ID=27089007

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9114256A Expired - Lifetime FR2669346B1 (en) 1990-11-20 1991-11-19 RECOMBINANT POXVIRUS VACCINE AGAINST MEALS.

Country Status (12)

Country Link
JP (2) JP3617668B2 (en)
AU (1) AU1253892A (en)
BE (1) BE1005908A5 (en)
CA (1) CA2096633A1 (en)
CH (1) CH683921A5 (en)
DE (2) DE4192786B4 (en)
FR (1) FR2669346B1 (en)
GB (2) GB2283021B (en)
IE (2) IE68404B1 (en)
IT (1) IT1252687B (en)
NL (2) NL195058C (en)
WO (1) WO1992008789A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338683A (en) 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5505941A (en) * 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US6248333B1 (en) 1990-04-04 2001-06-19 Health Research Inc. Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5989561A (en) * 1991-03-07 1999-11-23 Virogenetics Corporation Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
KR100242671B1 (en) * 1991-03-07 2000-03-02 고돈 에릭 Genetically engineered vaccine strain
AU672581B2 (en) * 1991-03-07 1996-10-10 Virogenetics Corporation Immunodeficiency virus recombinant poxvirus vaccine
JPH06505397A (en) * 1991-03-20 1994-06-23 ヴァイロジェネティクス　コーポレイション malaria recombinant poxvirus
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
CN1089370C (en) * 1994-12-08 2002-08-21 中国预防医学科学研究院病毒学研究所 Recombination vaccinia virus for expression of measles virus L4 strain hemagglutinin and fusion protein gene
AU2118997A (en) * 1996-02-05 1997-08-22 Johns Hopkins University, The Measles immunization by dna transcription unit inoculation
CA2289731A1 (en) 1997-05-09 1998-11-12 The United States Of America, Represented By The Secretary, Department O F Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
EP1095948A1 (en) * 1999-10-28 2001-05-02 Universitätsklinikum Freiburg Idiotype vaccines
CN100446812C (en) * 2001-03-08 2008-12-31 美国国有健康与人类服务部 MVA expressing modified HIV envelope, GAG, and pol genes
AR052743A1 (en) * 2006-04-11 2007-03-28 Inst Nac De Tecnologia Agropec PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2617715B1 (en) * 1987-07-07 1990-08-31 Transgene Sa VIRAL VECTOR AND RECOMBINANT DNA ENCODING FOR ONE OR MORE SURFACE PROTEINS (HA AND / OR F) OF A MORBILLIVIRUS, INFECTED CELL CULTURE, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
DE10399031I1 (en) * 1987-08-28 2004-01-29 Health Research Inc Recombinant viruses.
FR2632863B2 (en) * 1987-10-29 1990-08-31 Transgene Sa RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES
JPH01218590A (en) * 1988-02-29 1989-08-31 Toa Nenryo Kogyo Kk Rinderpest virus vaccine using recombinant vaccinia virus

Also Published As

Publication number Publication date
GB9500214D0 (en) 1995-03-01
DE4192786B4 (en) 2006-08-24
FR2669346A1 (en) 1992-05-22
CA2096633A1 (en) 1992-05-21
GB2264949A (en) 1993-09-15
JPH06502996A (en) 1994-04-07
IE71643B1 (en) 1997-02-26
GB2283021B (en) 1995-07-05
DE4192786T1 (en) 1994-01-13
NL195095C (en) 2004-01-21
JP3617668B2 (en) 2005-02-09
AU1253892A (en) 1992-06-11
IT1252687B (en) 1995-06-23
GB9309414D0 (en) 1993-07-14
JP3824619B2 (en) 2006-09-20
GB2264949B (en) 1995-07-05
NL195058C (en) 2003-07-01
NL9120026A (en) 1993-09-01
CH683921A5 (en) 1994-06-15
BE1005908A5 (en) 1994-03-08
NL9900036A (en) 2003-10-01
JP2005040129A (en) 2005-02-17
GB2283021A (en) 1995-04-26
IE913960A1 (en) 1992-05-20
IE68404B1 (en) 1996-06-12
ITMI913092A0 (en) 1991-11-20
ITMI913092A1 (en) 1993-05-20
WO1992008789A1 (en) 1992-05-29

Similar Documents

Publication Publication Date Title
FR2669346B1 (en) RECOMBINANT POXVIRUS VACCINE AGAINST MEALS.
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
DE68921923D1 (en) Recombinant coccidiosis vaccine.
GB9303023D0 (en) Flavivirus recombinant poxvirus vaccine
LU91327I2 (en) Human papillomavirus vaccine types 56,11,16,18Ü (recombinant, adsorbed)
CY2007016I1 (en) HPV VACCINE
FR2629717B1 (en) VACCINE PREPARATION
DE69016956D1 (en) Recombinant turkey herpes virus and derived live vaccine vector.
EP0676954A4 (en) Human immunodeficiency virus decoy.
EP0621339A3 (en) Immunogenic human influenza a virus haemagglutinin polypeptides.
DE3850019D1 (en) Recombinant avipox virus.
DZ1706A1 (en) Hepatitis A vaccine.
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
ZA924150B (en) Vaccine for human immunodeficiency virus
DE69230627T2 (en) Recombinant avipox virus
EP0728842A3 (en) Live recombinant avian vaccine based on an avianherpes virus, against Gumboro disease
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
DE68914043D1 (en) Coccidiosis vaccine.
NO912271D0 (en) SOMATOSTATIN PREPARATIONS, THEIR PREPARATION AND USE.
AU6358190A (en) Polypeptide vaccines against foot-and-mouth disease virus
FI934777A0 (en) MULTIPEL HEPATITIS B VIRUS YTPROTEINER SOM BILDAR PARTIKLAR
DE69020848D1 (en) IBV vaccine.
DE68918189D1 (en) Neisseria vaccine.
DE58905160D1 (en) PHARMACEUTICAL PREPARATION.
EP0537232A4 (en) Recombinant pigeon pox virus vaccine